Pengjiao An

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Smoking Cessation

Mechanical Ventilation

Palliative Care

Top Venues

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Dou, Xin Liu, Pengjiao An, Wei Zuo, Bo Zhang
Real-world safety profile of tetracyclines in children younger than 8 years old: an analysis of FAERS database and review of case report. Expert opinion on drug safety 23 (7) (2024)
Wei Dou, Xin Liu, Pengjiao An, Wei Zuo, Bo Zhang
Real-world safety profile of tetracyclines in children younger than 8 years old: an analysis of FAERS database and review of case report. Expert opinion on drug safety 23 (7) (2024)
Wei Dou, Xin Liu, Pengjiao An, Wei Zuo, Bo Zhang
Real-world safety profile of tetracyclines in children younger than 8 years old: an analysis of FAERS database and review of case report. Expert opinion on drug safety (2024)
Wei Dou, Xin Liu, Pengjiao An, Wei Zuo, Bo Zhang
Real-world safety profile of tetracyclines in children younger than 8 years old: an analysis of FAERS database and review of case report. Expert opinion on drug safety (2024)
Pengjiao An, Xin Liu, Bo Zhang
Safety profile of clobazam in the real world: an analysis of FAERS database and systematic review of case reports. Expert opinion on drug safety (2023)
Zhuo Sun, Xin Liu, Pengjiao An, Bo Zhang
Real-world safety profile of riluzole: a systematic analysis of data from the FAERS database and case reports. Expert opinion on drug safety (2023)